An Accra Accelerator Dropped Equity Entirely — and Got Six Times the Applications

Gyensu Labs ran four cohorts on the standard model: $50,000 for 7% of the company, twelve weeks, demo day at the end. For its fifth, it took the equity out entirely and replaced it with a 3% revenue share that terminates once the program has been repaid three times over, or after five years, whichever comes first.

Applications went from 340 to 2,100. More interesting than the volume is the composition: the share of applicants with existing revenue rose from 22% to 58%, and the share from outside Accra and Kumasi more than doubled. Founders with something already working, it turns out, had been quietly declining to trade 7% for twelve weeks of programming.

"Seven percent of a company that works is worth a great deal more than fifty thousand dollars, and every founder with traction has already done that arithmetic," said program director Yaw Boateng. "We were selecting for people who could not do the arithmetic or had no alternative. That is not a portfolio strategy, that is adverse selection."

The open question is whether the returns work. Equity-free models cap the upside precisely on the companies that succeed most, and Gyensu concedes the model cannot fund a $2 billion outcome. Its argument is that the last four cohorts did not produce one either, and that a portfolio of repaid revenue shares from companies that actually survive is a better business than a book of dead 7% stakes.